Abstract
The distribution kinetics of adriamycin in the rat were analyzed by using a multicompartment mathematical model. The set of a priori unknown model parameters, the drug rate constants, were estimated from 48 hr multicompartment drug distribution data by applying multivanate system identification techniques. Simultaneously, the information in all the measurements is exploited for the calculation of drug concentration time curves of each compartment of the model. No quantitative a priori information is required in the form of blood flow or membrane transport limitations. This approach requires only qualitative a priori biological information in the form of a mathematical model structure and successfully analyzes complex multidimensional pharmacokinetics. It results in a compact and realistic representation of physiologic drug transport processes.
Similar content being viewed by others
References
S. K. Carter. Adriamycin—a review.J. Natl. Cancer Inst. 55:1265–1274 (1975).
L. Lenaz and J. A. Page. Cardiotoxicity of adriamycin and related anthracyclines.Cancer Treat. Rev. 3:111–120 (1976).
R. S. Benjamin, C. E. Riggs, and N. R. Bachur, Pharmacokinetics and metabolism of adriamycin in man.Clin. Pharmacol. Ther. 14:592–600 (1973).
R. S. Benjamin. Clinical pharmacology of adriamycin (NSC-123127).Cancer Chemother. Rep. Part 3 6(2):183–185 (1975).
C. E. Myers. The anthracyclines. In H. M. Pinedo (ed.),Cancer Chemotherapy, Elsevier/North-Holland, New York, 1980, pp. 66–82.
K. K. Chan, J. L. Cohen, J. F. Gross, K. J. Himmelstein, J. R. Bateman, Y. T. Lee, and A. S. Marlis. Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model.Cancer Treat. Rep. 62:1161–1171 (1978).
R. L. Dedrick, D. D. Forrester, and K. H. W. Ho. In vitro-in vivo correlation of drug metabolism. Deamination of 1-β-D-arabinofuranosylcytosine.Biochem. Pharmacol.,21:1–16 (1972).
L. Iterlikkis, E. Ortega, R. Solomon, and J. L. Day. Pharmacokinetics of mercapturine.J. Pharm. Sci. 66:1454–1457 (1977).
K. B. Bischoff and R. L. Dedrick. Thiopental pharmacokinetics.J. Pharm. Sci. 57(8):1346–1351 (1968).
E. R. Carson and E. A. Jones. Use of kinetic analysis and mathematical modeling in the study of metabolic pathway in vivo.N. Engl. J. Med. 300(18):1016–1027.
S. D. Reich, F. Steinberg, N. R. Bachen, C. E. Riggs, Jr., R. Goebel, and M. Berman. Mathematical model for adriamycin (Doxorubicin) pharmacokinetics.Cancer Chemother. Pharmacol. 3:125–131 (1979).
L. Campello and C. Cobelli. Parameter estimation of biological stochastic compartmental models: an application. IEEE Trans. Biomed. Eng.25:139–146 (1978).
P. Eijkoff.System Identification. State and Parameter Estimation. John Wiley & Sons, New York, 1974.
H. S. Schwartz. A fluorometric assay for daunomycin and adriamycin in animal tissues.Biochem. Med. 7:396–404 (1973).
K. B. Bischoff. Some fundamental considerations of the applications of pharmacokinetics to cancer chemotherapy.Cancer Chemother. Rep. 59:777–793 (1975).
T. Teorell. Kinetics of distribution of substances administered to the body.Arch. Int. Pharmacodyn. Ther. 57:205–240 (1937).
J. G. Wagner.Fundamentals of Clinical Pharmacokinetics, Drug Intelligence Publications, Hamilton, 1975.
P. M. Wilkinson, M. Israel, W. J. Pegg, and E. Frei, III. Comparative metabolism and excretion of adriamycin in man, monkey and rat.Cancer Chemother. Pharmacol. 2:121–125 (1979).
L. Michaelis and M. L. Menten. Die Kinetik der Invertinwerkung.Biochem. Z. 49:333–369 (1913).
H. S. G. Chen and J. F. Gross. Physiologically based pharmacokinetic models for anticancer drugs; general review.Cancer Chemother. Pharmacol. 2:85–94 (1979).
P. A. Harris and J. F. Gross. Preliminary pharmacokinetic model for adriamycin.Cancer Chemother. Rep. 54:819–825 (1975).
R. P. Brent.Algorithms for Minimization Without Derivatives. Prentice-Hall, Englewood Cliffs, N.J., 1973, pp. 116–167.
J. A. Mulder. Aircraft performance measurements in nonsteady flights. InProc. 3rd IFAC Symp. Identification and System Parameter Estimation. North-Holland, Amsterdam 1973, pp. 1131–1145.
N. K. Gupta. Computational aspects of maximum likelihood estimation and reduction in sensitivity function calculations.IEEE Trans. Automatic Control AC-19(6):774–783 (1974).
H. Kwakernaak and R. Sivan,Linear Optimal Control Systems. Wiley-Interscience, New York, 1972, pp. 11–37.
Author information
Authors and Affiliations
Additional information
This study was supported by the Koningin Wilhelmina Fonds of the Dutch National Cancer League.
Rights and permissions
About this article
Cite this article
Sonneveld, P., Mulder, J.A. Development and identification of a multicompartment model for the distribution of adriamycin in the rat. Journal of Pharmacokinetics and Biopharmaceutics 9, 577–601 (1981). https://doi.org/10.1007/BF01061027
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01061027